首页> 外文期刊>Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer >Smoking History Predicts Sensitivity to PARP Inhibitor Veliparib in Patients with Advanced Non–Small Cell Lung Cancer: Methodological Issues

【24h】

Smoking History Predicts Sensitivity to PARP Inhibitor Veliparib in Patients with Advanced Non–Small Cell Lung Cancer: Methodological Issues

机译：吸烟病史预测PARP抑制剂Veliparib在高级非小细胞肺癌患者中对PARP抑制剂的敏感性：方法论问题

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 |2017年第8期|共2页
作者
Saeid Safiri; Erfan Ayubi;
展开▼
作者单位

Managerial Epidemiology Research Center Department of Public Health School of Nursing and;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Smoking History Predicts Sensitivity to PARP Inhibitor Veliparib in Patients with Advanced Non–Small Cell Lung Cancer: Methodological Issues [J] . Saeid Safiri, Erfan Ayubi Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2017,第8期

机译：吸烟病史预测PARP抑制剂Veliparib在高级非小细胞肺癌患者中对PARP抑制剂的敏感性：方法论问题
2. Smoking History Predicts Sensitivity to PARP Inhibitor Veliparib in Patients with Advanced Non–Small Cell Lung Cancer: Methodological Issues [J] . Saeid Safiri, Erfan Ayubi Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2017,第8期

机译：吸烟病史预测PARP抑制剂Veliparib在高级非小细胞肺癌患者中对PARP抑制剂的敏感性：方法论问题
3. Smoking History Predicts Sensitivity to PARP Inhibitor Veliparib in Patients with Advanced Non–Small Cell Lung Cancer [J] . Reck, M.aEmail Author, Blais, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2017,第7期

机译：吸烟病史预测对高小细胞肺癌患者的PARP抑制剂Veliparib的敏感性
4. Gene expression profiles predict survival of patients with advanced non-small cell lung cancers [C] . Harun Roslan, Hadi Jalal, Mhazir Nur Shukriyah, 2011 Fourth International Conference on Modeling, Simulation and Applied Optimization . 2011

机译：基因表达谱预测晚期非小细胞肺癌患者的生存
5. Enhancing the Therapeutic Effects of Low Doses of Ionizing Radiation in Non-Small Cell Lung Cancers Using a Combination of PARP Inhibitors and DNA Demethylating Agents. [D] . Biondi, Christopher Anthony. 2016

机译：使用PARP抑制剂和DNA去甲基化剂的组合增强非小细胞肺癌低剂量电离辐射的治疗效果。
6. A detailed smoking history and determination of MYC status predict response to checkpoint inhibitors in advanced non-small cell lung cancer [O] . Michelle Chiu, Mary Beth Lipka, Priyanka Bhateja, 2020

机译：详细的吸烟史和MYC状况的确定可预测晚期非小细胞肺癌对检查点抑制剂的反应
7. Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small-cell lung cancer [O] . Vincent A. Miller, Mark G. Kris, Neelam Shah, 2004

机译：细支气管肺泡病理学亚型和吸烟史预测晚期非小细胞肺癌对吉非替尼的敏感性

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号